Skip to main content

SYSTEMATIC REVIEW article

Front. Med.

Sec. Precision Medicine

Volume 12 - 2025 | doi: 10.3389/fmed.2025.1523902

This article is part of the Research Topic AI-Driven Advances in Immunology and Immune-Mediated Disorders View all articles

Opportunities and challenges with Artificial intelligence in allergy and immunology: a bibliometric study

Provisionally accepted
Ningkun Xiao Ningkun Xiao 1Xinlin Huang Xinlin Huang 2Yujun Wu Yujun Wu 3Baoheng Li Baoheng Li 2Wanli Zang Wanli Zang 4Khyber Shinwari Khyber Shinwari 5Irina A Tuzankina Irina A Tuzankina 6Valery A Chereshnev Valery A Chereshnev 6Guojun Liu Guojun Liu 7*
  • 1 Department of Immunochemistry, Institute of Chemical Technology, Ural Federal University, Ekaterinburg, Russia
  • 2 Ural Federal University, Yekaterinburg, Sverdlovsk Oblast, Russia
  • 3 West China School of Public Health, Sichuan University, Chengdu, Sichuan Province, China
  • 4 Harbin Sport University, Harbin, Heilongjiang Province, China
  • 5 Speenghar institute of higher education, Nangrahar, Afghanistan
  • 6 Institute of Immunology and Physiology (RAS), Yekaterinburg, Russia
  • 7 Inner Mongolia University of Science and Technology, Baotou, Inner Mongolia Autonomous Region, China

The final, formatted version of the article will be published soon.

    Artificial intelligence (AI) is increasingly recognized in the fields of allergy and immunology, profoundly influencing its development. This study employed bibliometric methods to provide a comprehensive research of AI applications in allergy and immunology, deeply discussing the current status, development trends, and future research hotspots. The goal is to help researchers quickly identify research hotspots and foster collaboration to advance the field. Our research reveals that 21,552 authors have published 3,883 related articles across 1,247 journals, with the USA and China leading in output and impact. Currently, we extensively use AI, particularly machine learning (ML) and deep learning (DL), in drug prediction and development, allergy and immunological disease classification and prediction, immune response exploration and modeling, decision support, diagnostics, digitalization and smart integration of healthcare systems, and medical education. It is evolving towards integration with personalized medical systems, offering substantial future application opportunities. Despite serious challenges in technology, ethics, and regulation, we believe AI will play a positive role globally, improving health conditions and enhancing well-being worldwide.

    Keywords: artificial intelligence, Allergy and Immunology, immunology, machine learning, deep learning, Health management, Bibliometric Study

    Received: 08 Nov 2024; Accepted: 27 Mar 2025.

    Copyright: © 2025 Xiao, Huang, Wu, Li, Zang, Shinwari, Tuzankina, Chereshnev and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Guojun Liu, Inner Mongolia University of Science and Technology, Baotou, 130012, Inner Mongolia Autonomous Region, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    95% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more